Skip to contentS
Sonoma Pharmaceuticals, Inc.
S
SNOASonoma Pharmaceuticals, Inc. Q1 2015 · 10-Q
Revenue$3.39M$3.39M+0.6% vs Q1 2014 Net Income-$70.00K-$70.00KN/M vs Q1 2014 EPS Diluted-$0.01-$0.01N/M vs Q1 2014 Gross Profit$1,906,000−13.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sonoma Pharmaceuticals, Inc. · CIK 1367083 · Engraved from SEC EDGAR
Operating Cash Flow-$1,346,000N/M Free Cash Flowderived-$1,367,000N/M Margins · derivedGross margin56.2%−9.1 pt vs Q1 2014
Operating margin-44.6%−11.2 pt vs Q1 2014
Net margin-2.1%+48.7 pt vs Q1 2014
ended Jun 30, 2014 · filed Aug 12, 2014 · 43 d after period end